MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1177/030089160509100613

Медицинская библиотека · Tumori · 2005

Serum markers and prognosis in locally advanced breast cancer.

Martínez-Trufero Javier, de Lobera Abigail Ruiz, Lao Juan, Puértolas Teresa, Artal-Cortés Angel, Zorrilla Mirian, Alonso Vicente, Pazo Roberto, Valero M Ignacia, Ríos-Mitchell M Jose, Calderero Verónica, Herrero Ana, Antón Antonio

СтатьяПеревод в очереди

Аннотация

BACKGROUND

Locally advanced breast cancer (LABC) represents a heterogeneous subgroup of breast cancer with an often dismal outcome. Identifying prognostic factors has acquired great significance for the selection of optimal treatment in individual patients.

METHODS

Between January 1993 and December 1997, 103 patients were treated in our institution with multimodality treatment consisting of neoadjuvant chemotherapy followed by surgery, adjuvant chemotherapy and radiotherapy; tamoxifen was added in hormone receptor-positive cases. In the search for prognostic factors well-established parameters (clinical, pathological and treatment-related) as well as new features with potential value (c-erbB-2, baseline serum levels of CA 15.3 and CEA) were included in the univariate and multivariate analysis.

RESULTS

At a median follow-up of 92 months (range, 8-130), the estimated five-year cancer-specific overall survival (OS) and disease-free survival (DFS) were 71.34% and 57.7%, respectively. Among the 22 different variables studied, only 10 were significantly correlated with OS and DFS. In multivariate analysis five retained independent prognostic value for both OS and DFS: tumor grade, serum markers, features of inflammatory breast cancer (IBC), response to neoadjuvant chemotherapy and lymph node status. With cutoff values of 35 U/mL for CA 15.3 and 5 ng/mL for CEA, the probability of five-year OS (Cox hazard ratio 3.91, P = 0.0009) and DFS (Cox hazard ratio 2.40, P = 0.02) decreased from 78% to 52% and from 68% to 47%, respectively, when at least one of these markers was abnormal.

CONCLUSIONS

Baseline serum levels of CEA and CA 15.3 emerged from this study as strong independent predictors of outcome in LABC, whose value adds to other established prognostic factors such as postoperative nodal status, IBC, histological grade and response to neoadjuvant chemotherapy.

Для цитирования: Martínez-Trufero Javier, de Lobera Abigail Ruiz, Lao Juan, Puértolas Teresa, Artal-Cortés Angel, Zorrilla Mirian, Alonso Vicente, Pazo Roberto, Valero M Ignacia, Ríos-Mitchell M Jose, Calderero Verónica, Herrero Ana, Antón Antonio. Serum markers and prognosis in locally advanced breast cancer.. Tumori. 2005. DOI: 10.1177/030089160509100613.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.